138 related articles for article (PubMed ID: 9066744)
1. Immunohistochemical detection of p53 and c-erbB-2 in oesophageal carcinoma; no correlation with prognosis.
Hardwick RH; Barham CP; Ozua P; Newcomb PV; Savage P; Powell R; Rahamin J; Alderson D
Eur J Surg Oncol; 1997 Feb; 23(1):30-5. PubMed ID: 9066744
[TBL] [Abstract][Full Text] [Related]
2. Human epidermal growth factor receptor-2 in oesophageal cancers: an observational study.
Al-Momani H; Barnes R; El-Hadi A; Shah R; Lewis WG; Edwards P
World J Gastroenterol; 2012 Nov; 18(44):6447-51; discussion p.6450. PubMed ID: 23197890
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
[TBL] [Abstract][Full Text] [Related]
4. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of p53, c-erbB-2 and epidermal growth factor receptor on head and neck carcinoma.
Parise Junior O; Carvalho LV; Miguel RE; Kowalski LP
Sao Paulo Med J; 2004 Nov; 122(6):264-8. PubMed ID: 15692721
[TBL] [Abstract][Full Text] [Related]
6. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
[TBL] [Abstract][Full Text] [Related]
7. Expression of c-erbB-2 and p53 in colorectal adenocarcinoma.
Sun XF; Carstensen JM; Nordenskjöld B
Anal Cell Pathol; 1995 Apr; 8(3):203-11. PubMed ID: 7547494
[TBL] [Abstract][Full Text] [Related]
8. Association of p53 expression with prognosis in patients with esophageal squamous cell carcinoma.
Yao W; Qin X; Qi B; Lu J; Guo L; Liu F; Liu S; Zhao B
Int J Clin Exp Pathol; 2014; 7(10):7158-63. PubMed ID: 25400812
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer.
Shpitz B; Bomstein Y; Sternberg A; Klein E; Liverant S; Groisman G; Bernheim J
J Surg Oncol; 2000 Dec; 75(4):252-7. PubMed ID: 11135266
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictive value of p53 mutation in patients with oesophageal squamous cell carcinomas: a prospective clinico-pathological study and survival analysis of 70 patients.
Lam KY; Tsao SW; Zhang D; Law S; He D; Ma L; Wong J
Int J Cancer; 1997 Apr; 74(2):212-9. PubMed ID: 9133458
[TBL] [Abstract][Full Text] [Related]
11. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
[TBL] [Abstract][Full Text] [Related]
12. Tumor marker expression is predictive of survival in patients with esophageal cancer.
Aloia TA; Harpole DH; Reed CE; Allegra C; Moore MB; Herndon JE; D'Amico TA
Ann Thorac Surg; 2001 Sep; 72(3):859-66. PubMed ID: 11565671
[TBL] [Abstract][Full Text] [Related]
13. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
14. p53, c-erbB-2 and nm23 expression have no prognostic significance in primary pulmonary adenocarcinoma.
MacKinnon M; Kerr KM; King G; Kennedy MM; Cockburn JS; Jeffrey RR
Eur J Cardiothorac Surg; 1997 May; 11(5):838-42. PubMed ID: 9196297
[TBL] [Abstract][Full Text] [Related]
15. p53 protein accumulation and p53 gene mutation in esophageal carcinoma. A molecular and immunohistochemical study with clinicopathologic correlations.
Coggi G; Bosari S; Roncalli M; Graziani D; Bossi P; Viale G; Buffa R; Ferrero S; Piazza M; Blandamura S; Segalin A; Bonavina L; Peracchia A
Cancer; 1997 Feb; 79(3):425-32. PubMed ID: 9028350
[TBL] [Abstract][Full Text] [Related]
16. c-erbB-2 and p53 expression in fallopian tube carcinoma.
Lacy MQ; Hartmann LC; Keeney GL; Cha SC; Wieand HS; Podratz KC; Roche PC
Cancer; 1995 Jun; 75(12):2891-6. PubMed ID: 7773939
[TBL] [Abstract][Full Text] [Related]
17. Oesophageal cancer composed of mixed histological types.
Kuwano H; Sadanaga N; Watanabe M; Yasuda M; Nozoe T; Sugimachi K
Eur J Surg Oncol; 1996 Jun; 22(3):225-31. PubMed ID: 8654601
[TBL] [Abstract][Full Text] [Related]
18. c-erbB-2 oncoprotein expression related to chemoradioresistance in esophageal squamous cell carcinoma.
Akamatsu M; Matsumoto T; Oka K; Yamasaki S; Sonoue H; Kajiyama Y; Tsurumaru M; Sasai K
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1323-7. PubMed ID: 14630269
[TBL] [Abstract][Full Text] [Related]
19. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53 protein in oesophageal carcinoma: clinicopathological correlation and prognostic significance.
Vijeyasingam R; Darnton SJ; Jenner K; Allen CA; Billingham C; Matthews HR
Br J Surg; 1994 Nov; 81(11):1623-6. PubMed ID: 7827889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
